Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20133033rdf:typepubmed:Citationlld:pubmed
pubmed-article:20133033lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20133033lifeskim:mentionsumls-concept:C0920317lld:lifeskim
pubmed-article:20133033lifeskim:mentionsumls-concept:C0162521lld:lifeskim
pubmed-article:20133033lifeskim:mentionsumls-concept:C0011945lld:lifeskim
pubmed-article:20133033lifeskim:mentionsumls-concept:C2917382lld:lifeskim
pubmed-article:20133033lifeskim:mentionsumls-concept:C1955832lld:lifeskim
pubmed-article:20133033lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:20133033lifeskim:mentionsumls-concept:C0205485lld:lifeskim
pubmed-article:20133033pubmed:issue3lld:pubmed
pubmed-article:20133033pubmed:dateCreated2010-3-1lld:pubmed
pubmed-article:20133033pubmed:abstractTextThe role of erythropoiesis-stimulating agents (ESAs) in treating the anemia of chronic kidney disease has been reevaluated in view of recent studies suggesting that the use of these agents may be associated with increased morbidity and mortality. This potential increased risk needs to be weighed against the potential benefit of ESAs in improving various aspects of health-related quality of life, in particular, exercise tolerance and physical functioning.lld:pubmed
pubmed-article:20133033pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20133033pubmed:languageenglld:pubmed
pubmed-article:20133033pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20133033pubmed:citationSubsetIMlld:pubmed
pubmed-article:20133033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20133033pubmed:statusMEDLINElld:pubmed
pubmed-article:20133033pubmed:monthMarlld:pubmed
pubmed-article:20133033pubmed:issn1523-6838lld:pubmed
pubmed-article:20133033pubmed:authorpubmed-author:EvansChristop...lld:pubmed
pubmed-article:20133033pubmed:authorpubmed-author:JohansenKirst...lld:pubmed
pubmed-article:20133033pubmed:authorpubmed-author:RevickiDennis...lld:pubmed
pubmed-article:20133033pubmed:authorpubmed-author:FinkelsteinFr...lld:pubmed
pubmed-article:20133033pubmed:authorpubmed-author:MayneTracy...lld:pubmed
pubmed-article:20133033pubmed:authorpubmed-author:GitlinMatthew...lld:pubmed
pubmed-article:20133033pubmed:copyrightInfoCopyright 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:20133033pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20133033pubmed:volume55lld:pubmed
pubmed-article:20133033pubmed:ownerNLMlld:pubmed
pubmed-article:20133033pubmed:authorsCompleteYlld:pubmed
pubmed-article:20133033pubmed:pagination535-48lld:pubmed
pubmed-article:20133033pubmed:meshHeadingpubmed-meshheading:20133033...lld:pubmed
pubmed-article:20133033pubmed:meshHeadingpubmed-meshheading:20133033...lld:pubmed
pubmed-article:20133033pubmed:meshHeadingpubmed-meshheading:20133033...lld:pubmed
pubmed-article:20133033pubmed:meshHeadingpubmed-meshheading:20133033...lld:pubmed
pubmed-article:20133033pubmed:meshHeadingpubmed-meshheading:20133033...lld:pubmed
pubmed-article:20133033pubmed:meshHeadingpubmed-meshheading:20133033...lld:pubmed
pubmed-article:20133033pubmed:meshHeadingpubmed-meshheading:20133033...lld:pubmed
pubmed-article:20133033pubmed:meshHeadingpubmed-meshheading:20133033...lld:pubmed
pubmed-article:20133033pubmed:year2010lld:pubmed
pubmed-article:20133033pubmed:articleTitleSystematic review and meta-analysis of exercise tolerance and physical functioning in dialysis patients treated with erythropoiesis-stimulating agents.lld:pubmed
pubmed-article:20133033pubmed:affiliationUniversity of California, San Francisco, CA, USA. kirsten.johansen@ucsf.edulld:pubmed
pubmed-article:20133033pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20133033pubmed:publicationTypeReviewlld:pubmed
pubmed-article:20133033pubmed:publicationTypeMeta-Analysislld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20133033lld:pubmed